EVI-1 oncogene expression predicts survival in chronic-phase CML patients resistant to imatinib treated with second-generation tyrosine kinase inhibitors (Q42882348)

From Wikidata
Jump to navigation Jump to search
scientific article published on 20 September 2010
edit
Language Label Description Also known as
English
EVI-1 oncogene expression predicts survival in chronic-phase CML patients resistant to imatinib treated with second-generation tyrosine kinase inhibitors
scientific article published on 20 September 2010

    Statements

    EVI-1 oncogene expression predicts survival in chronic-phase CML patients resistant to imatinib treated with second-generation tyrosine kinase inhibitors (English)
    0 references
    0 references
    Mustafa Daghistani
    Jamshid Sorouri Khorashad
    Christos Paliompeis
    Dragana Milojkovic
    Valeria A De Melo

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit